Discontinuation of warfarin is unnecessary in total knee arthroplasty.

PubWeight™: 0.88‹?›

🔗 View Article (PMC 2795823)

Published in Clin Orthop Relat Res on January 01, 2010

Authors

David A Rhodes1, Erik P Severson, Jeffrey T Hodrick, Harold K Dunn, Aaron A Hofmann

Author Affiliations

1: Department of Orthopaedics, University of Utah, 590 Wakara Way, Salt Lake City, UT 84108, USA.

Articles cited by this

Projections of primary and revision hip and knee arthroplasty in the United States from 2005 to 2030. J Bone Joint Surg Am (2007) 24.18

Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest (2004) 11.84

Antithrombotic therapy for venous thromboembolic disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest (2008) 7.12

Epidural anaesthesia and analgesia and outcome of major surgery: a randomised trial. Lancet (2002) 5.27

Management of anticoagulation before and after elective surgery. N Engl J Med (1997) 5.10

Perioperative management of patients receiving oral anticoagulants: a systematic review. Arch Intern Med (2003) 5.02

Perioperative epidural analgesia and outcome after major abdominal surgery in high-risk patients. Anesth Analg (2003) 4.15

Future clinical and economic impact of revision total hip and knee arthroplasty. J Bone Joint Surg Am (2007) 3.78

Optimum duration of anticoagulation for deep-vein thrombosis and pulmonary embolism. Research Committee of the British Thoracic Society. Lancet (1992) 3.60

Death and thromboembolic disease after total hip replacement. A series of 1162 cases with no routine chemical prophylaxis. J Bone Joint Surg Br (1995) 3.29

Incidence of symptomatic venous thromboembolism after different elective or urgent surgical procedures. Thromb Haemost (2003) 2.62

Comparison of enoxaparin and warfarin for the prevention of venous thromboembolic disease after total hip arthroplasty. Evaluation during hospitalization and three months after discharge. J Bone Joint Surg Am (1999) 1.84

Ardeparin sodium for extended out-of-hospital prophylaxis against venous thromboembolism after total hip or knee replacement. A randomized, double-blind, placebo-controlled trial. Ann Intern Med (2000) 1.71

Effect of epidural anesthesia and analgesia on perioperative outcome: a randomized, controlled Veterans Affairs cooperative study. Ann Surg (2001) 1.69

A meta-analysis of thromboembolic prophylaxis following elective total hip arthroplasty. J Bone Joint Surg Am (2000) 1.57

Risk factors and clinical impact of postoperative symptomatic venous thromboembolism. J Vasc Surg (2007) 1.47

Late occurring clinical deep vein thrombosis in joint-operated patients. Acta Orthop Scand (2000) 1.42

Stroke risk in anticoagulated patients with atrial fibrillation undergoing endoscopy. Neurology (2003) 1.28

Warfarin-induced skin necrosis and venous limb gangrene in the setting of heparin-induced thrombocytopenia. Arch Intern Med (2004) 1.23

Elective hand surgery in patients taking warfarin. J Hand Surg Br (2004) 1.09

Decline of proteins C and S and factors II, VII, IX and X during the initiation of warfarin therapy. Thromb Res (1987) 1.06

Stopping warfarin therapy is unnecessary for hand surgery. J Hand Surg Br (2004) 1.02

Myths of dental surgery in patients receiving anticoagulant therapy. J Am Dent Assoc (2000) 1.02

Anticoagulants and cataract surgery. Ophthalmic Surg (1988) 0.99

Symptomatic venous thromboembolism after total knee replacement. J Bone Joint Surg Br (1997) 0.99

The Mark Coventry Award: Prevention of readmission for venous thromboembolism after total knee arthroplasty. Clin Orthop Relat Res (2006) 0.98

The incidence of symptomatic venous thromboembolism during and after prophylaxis with enoxaparin: a multi-institutional cohort study of patients who underwent hip or knee arthroplasty. Canadian Collaborative Group. Arch Intern Med (1998) 0.93

The efficacy of prophylaxis with low-dose warfarin for prevention of pulmonary embolism following total hip arthroplasty. J Bone Joint Surg Am (1997) 0.91

Complications associated with warfarin prophylaxis in total knee arthroplasty. Clin Orthop Relat Res (1987) 0.87

Cutaneous surgery in patients receiving warfarin therapy. Dermatol Surg (2001) 0.86

Warfarin therapy and cataract surgery. Clin Experiment Ophthalmol (2000) 0.86

Coagulation changes in elective surgery and trauma. Ann Surg (1981) 0.85

The John Charnley Award: prevention of readmission for venous thromboembolic disease after total hip arthroplasty. Clin Orthop Relat Res (2005) 0.84

Comparison of general and epidural anesthesia in patients undergoing primary unilateral THR. Orthopedics (1997) 0.84

The safety of open inguinal herniorraphy in patients on chronic warfarin therapy. Am J Surg (2006) 0.84

Comparison of a nomogram and physician-adjusted dosage of warfarin for prophylaxis against deep-vein thrombosis after arthroplasty. J Bone Joint Surg Am (2002) 0.79

Complications of cutaneous surgery in patients who are taking warfarin, aspirin, or nonsteroidal anti-inflammatory drugs. Arch Dermatol (1996) 0.79

Articles by these authors

Highly crosslinked polyethylene is safe for use in total knee arthroplasty. Clin Orthop Relat Res (2008) 1.18

Total knee arthroplasty in juvenile rheumatoid arthritis. J Bone Joint Surg Am (2005) 1.07

Simultaneous anterior-posterior approach through a costotransversectomy for the treatment of congenital kyphosis and acquired kyphoscoliotic deformities. J Bone Joint Surg Am (2005) 1.05

Sequelae of Perthes disease: treatment with surgical hip dislocation and relative femoral neck lengthening. J Pediatr Orthop (2010) 1.00

Ceramic-on-ceramic total hip arthroplasty in patients younger than 20 years. J Arthroplasty (2011) 0.95

Determining relevance of a weight-bearing ovine model for bone ingrowth assessment. J Biomed Mater Res A (2004) 0.93

Oxidative degradation in highly cross-linked and conventional polyethylene after 2 years of real-time shelf aging. Biomaterials (2005) 0.83

Complex Achilles reconstruction for massive soft tissue loss: allograft, autograft, and use of a temporary cement spacer. J Orthop Trauma (2010) 0.81

Revision of well-fixed cementless acetabular components for polyethylene failure. Clin Orthop Relat Res (2003) 0.79

Does using autograft bone chips achieve consistent bone ingrowth in primary TKA? Clin Orthop Relat Res (2012) 0.78

The "banana peel" exposure method in revision total knee arthroplasty. Am J Orthop (Belle Mead NJ) (2007) 0.78

Postoperative morbidity and mortality following total knee arthroplasty with computer navigation. Knee (2009) 0.78

No difference in 90-day complications between bilateral unicompartmental and total knee arthroplasty. Am J Orthop (Belle Mead NJ) (2014) 0.76

Results of bilateral combined hip and knee arthroplasty in very young patients with juvenile rheumatoid arthritis. Arch Orthop Trauma Surg (2007) 0.75

Comparison of screw and screwless fixation in cementless total knee arthroplasty. Orthopedics (2008) 0.75

Bone viability determination in human cancellous bone from patients undergoing revision hip arthroplasty. J Arthroplasty (2004) 0.75